Right data for right patient-a precisionFDA NCI-CPTAC Multi-omics Mislabeling Challenge

Nat Med. 2018 Sep;24(9):1301-1302. doi: 10.1038/s41591-018-0180-x.


To address a critical roadblock that can occur in translational and clinical research, the National Cancer Institute and the Food and Drug Administration, in coordination with the DREAM Challenges, are launching the first computational challenge using multi-omics datasets to detect and correct specimen mislabeling.

MeSH terms

  • Genomics*
  • Humans
  • National Cancer Institute (U.S.)*
  • Proteomics*
  • Staining and Labeling*
  • United States
  • United States Food and Drug Administration*